SCHEMBL9112182

SCHEMBL9112182

CO[C@H]1O[C@H](COC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.51
USP2 O75604 2/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
LGALS8 O00214 2/20 0.47
LGALS3 P17931 2/20 0.46
LGALS9 O00182 1/20 0.46
LGALS1 P09382 1/20 0.46
LGALS7; LGALS7B P47929 1/20 0.46
PTPN2 P17706 1/20 0.46
PTPN11 Q06124 1/20 0.46
LGALS4 P56470 1/20 0.46
ALDH1A1 P00352 1/20 0.45
SELP P16109 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
F11 P03951 2/20 0.44
TMPRSS2 O15393 1/20 0.44
PDE5A O76074 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486956 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL21778321 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13672342 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL5981712 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL15095568 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13151560 0.96 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL14440519 0.94 PTPN1 (0.50) PTPN1USP2MEN1POLBKMT2A
SCHEMBL7150482 0.93 LGALS8 (0.53) PTPN1USP2MEN1POLBKMT2A
SCHEMBL22984008 0.91 PTPN1 (0.57) PTPN1USP2MEN1POLBKMT2A
SCHEMBL22983992 0.91 PTPN1 (0.57) PTPN1USP2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174132-B2 Heparan sulfate synthesis UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2019-01-08 US disclosed
US-20160060365-A1 HEPARAN SULFATE SYNTHESIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2016-03-03 US disclosed
US-20120142560-A1 HEPARAN SULFATE SYNTHESIS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174132-B2 Heparan sulfate synthesis HPSE, STT3B, DDOST PTPN1 975/4885USP2 903/4885MEN1 2023/4885
US-20160060365-A1 HEPARAN SULFATE SYNTHESIS HPSE, STT3B, DDOST PTPN1 975/4885USP2 903/4885MEN1 2023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.